Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
42.78B | 39.59B | 32.76B | 25.83B | 67.49B | 163.29B | Gross Profit |
15.07B | 13.70B | 11.95B | 8.35B | 3.60B | 14.26B | EBIT |
1.74B | 1.21B | 820.00M | -833.00M | -6.23B | 1.10B | EBITDA |
4.33B | 3.57B | 3.17B | 1.65B | -4.03B | 2.47B | Net Income Common Stockholders |
1.37B | 1.12B | 1.42B | -1.12B | -6.66B | 121.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
38.23B | 33.92B | 26.36B | 24.36B | 15.13B | 23.87B | Total Assets |
93.99B | 90.27B | 74.80B | 64.60B | 52.78B | 58.61B | Total Debt |
17.87B | 18.63B | 21.22B | 25.04B | 28.11B | 12.60B | Net Debt |
-20.36B | -15.29B | -5.13B | 679.00M | 12.97B | -11.27B | Total Liabilities |
87.43B | 84.73B | 70.44B | 61.79B | 50.88B | 52.59B | Stockholders Equity |
6.56B | 5.54B | 4.35B | 2.81B | 1.85B | 5.95B |
Cash Flow | Free Cash Flow | ||||
0.00 | 10.55B | 5.84B | 10.46B | -25.34B | -10.24B | Operating Cash Flow |
0.00 | 12.38B | 9.36B | 13.06B | -21.86B | -2.35B | Investing Cash Flow |
0.00 | -2.22B | -3.56B | -2.70B | -4.16B | -7.96B | Financing Cash Flow |
0.00 | -2.60B | -3.80B | -1.13B | 17.29B | 8.98B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $714.54B | 31.44 | 14.25% | 1.22% | 6.67% | 114.29% | |
74 Outperform | ¥1.34T | 29.74 | 1.66% | 24.10% | 11.27% | ||
66 Neutral | ¥44.42B | 27.42 | ― | 14.09% | 15.57% | ||
65 Neutral | $331.94B | 13.83 | 10.56% | 1.86% | 8.46% | ― | |
64 Neutral | $4.43B | 12.01 | 5.16% | 249.23% | 4.03% | -11.73% | |
63 Neutral | $420.34B | 39.06 | 2.71% | 3.02% | -2.48% | 458.59% | |
58 Neutral | ¥824.90B | ― | -24.51% | 4.31% | 6.88% | -1044.58% |